Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	8 Months Ended
	Sep. 11, 2016		Sep. 06, 2015
Cash flows from operating activities:
Net income	$ 141,945		$ 130,030
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	25,460		22,695
Loss (gain) on sale/disposal of assets	473		(73)
Amortization of debt issuance costs	4,562		3,825
Provision for deferred income taxes	2,657		959
Non-cash compensation expense	12,344		11,188
Tax impact from equity-based compensation	(41,479)		(15,745)
Other	(406)		(1,216)
Changes in operating assets and liabilities	17,061		15,645
Net cash provided by operating activities	162,617		167,308
Cash flows from investing activities:
Capital expenditures	(38,254)		(33,834)
Proceeds from sale of assets	4,658		10,464
Changes in restricted cash	57,371		29,933
Other	(1,669)		1,304
Net cash provided by investing activities	22,106		7,867
Cash flows from financing activities:
Proceeds from issuance of long-term debt	63,000		5,000
Repayments of long-term debt and capital lease obligations	(77,592)		(5,198)
Proceeds from exercise of stock options	12,324		4,459
Tax impact from equity-based compensation	41,479		15,745
Purchases of common stock	(283,858)		(138,550)
Tax payments for restricted stock upon vesting	(5,605)		(7,442)
Payments of common stock dividends and equivalents	(37,548)		(48,141)
Net cash used in financing activities	(287,800)		(174,127)
Effect of exchange rate changes on cash and cash equivalents	(391)		603
Change in cash and cash equivalents	(103,468)		1,651
Cash and cash equivalents, at beginning of period	133,449	[1]	30,855
Cash and cash equivalents, at end of period	$ 29,981		$ 32,506

[1] The balance sheet at January 3, 2016 has been derived from the audited consolidated financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.